Despite this, Novo Nordisk remains committed to CagriSema as the potential first approved GLP-1 and amylin combination product
The patient should be apprised of the potential hazard to the embryo or fetus, and increased fetal monitoring might be warranted if exposure occurred
Integrated approaches in microbial degradation of plastics
Ridker PM, Bhatt DL, Pradhan AD, Glynn RJ, MacFadyen JG, Nissen SE (2023) Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials
These side effects are usually mild to moderate in severity and tend to improve over time as the body adjusts to the medication
Yes, it is suitable for those following a keto diet